Abiopharma

News list

Bassiouni Allison 🟢 acquired 2.5M shares (1 derivative) of Alight, Inc. / Delaware (ALIT) Transaction Date: Mar 25, 2026 | Filing ID: 021529

Full text

News bot March 26, 2026, 10:34 p.m.
🔍 Bassiouni Allison (Executive)

Company: Alight, Inc. / Delaware (ALIT)

Report Date: 2026-03-25
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 2
- Total shares acquired: 2,500,000
- Total shares held: 772,987
Detailed Transactions and Holdings:
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-25 | Code: H | shares_owned_after: 728,713.00
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: Spouse | shares_owned_after: 44,274.00
- Acquired 2,500,000 shares of Performance Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,500,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: On March 25, 2026, the reporting person was granted 2,500,000 performance stock Units. Each performance stock unit represents a contingent right to receive one share of Alight, Inc.'s Class A Common Stock.
- F2: The performance stock units vest and become earned in up to 25% increments based on the achievement of specified stock price performance hurdles during a five-year performance period, beginning on April 1, 2026, and ending on December 31, 2030, and subject to service-based vesting conditions.